Terms: = Colorectal cancer AND MYD88, Q99836, MYD88D, 4615 AND Prognosis
7 results:
1. colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/myd88 pathway.
Andreuzzi E; Fejza A; Polano M; Poletto E; Camicia L; Carobolante G; Tarticchio G; Todaro F; Di Carlo E; Scarpa M; Scarpa M; Paulitti A; Capuano A; Canzonieri V; Maiero S; Fornasarig M; Cannizzaro R; Doliana R; Colombatti A; Spessotto P; Mongiat M
J Exp Clin Cancer Res; 2022 Feb; 41(1):60. PubMed ID: 35148799
[TBL] [Abstract] [Full Text] [Related]
2. Aberrant expression of myd88 via RNA-controlling CNOT4 and EXOSC3 in colonic mucosa impacts generation of colonic cancer.
Tsuda M; Noguchi M; Kurai T; Ichihashi Y; Ise K; Wang L; Ishida Y; Tanino M; Hirano S; Asaka M; Tanaka S
Cancer Sci; 2021 Dec; 112(12):5100-5113. PubMed ID: 34626022
[TBL] [Abstract] [Full Text] [Related]
3. Cell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancer.
Niu Z; Tang W; Liu T; Xu P; Zhu D; Ji M; Huang W; Ren L; Wei Y; Xu J
Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):1007-1017. PubMed ID: 30239551
[TBL] [Abstract] [Full Text] [Related]
4. Dual functional roles of the myd88 signaling in colorectal cancer development.
Wang L; Yu K; Zhang X; Yu S
Biomed Pharmacother; 2018 Nov; 107():177-184. PubMed ID: 30086464
[TBL] [Abstract] [Full Text] [Related]
5. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract] [Full Text] [Related]
6. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.
Wang EL; Qian ZR; Nakasono M; Tanahashi T; Yoshimoto K; Bando Y; Kudo E; Shimada M; Sano T
Br J Cancer; 2010 Mar; 102(5):908-15. PubMed ID: 20145615
[TBL] [Abstract] [Full Text] [Related]
7. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness.
Ghilardi G; Biondi ML; Mangoni J; Leviti S; DeMonti M; Guagnellini E; Scorza R
Clin Cancer Res; 2001 Aug; 7(8):2344-6. PubMed ID: 11489811
[TBL] [Abstract] [Full Text] [Related]
